Sun Pharma introduces anti-cancer product in Europe

Posted on:12 Jul 2016 11:53:48

Sun Pharma introduces anti-cancer product in Europe
12 July 2016 Current Affairs GK: Sun Pharmaceutical Industries announced rollout of Gemcitabine InfuSMART, on Monday, used in treatment of cancer, in Europe.

Sun Pharma has announced rollout of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag.

Sun Pharma's Gemcitabine InfuSMART ready-to-administer infusion products provide the combined advantage of long stable compounded medicine along with safety... Traditionally, such medicines are compounded at hospitals (in-house) or outsourced to compounding pharmacies, making it a time-consuming and potentially hazardous process.

Launch of InfuSMART will help us remain a meaningful player in the global oncology therapy market by offering differentiating cancer treatment solutions. We believe there are opportunities for us to expand our portfolio of ready-to-administer products across multiple therapies where time and safety are an important element of treatment.

Sun Pharma has received regulatory approval to produce Gemcitabine InfuSMART in eight key SKUs (stock keeping units).

More InfuSMART oncology products are currently in Sun Pharma's pipeline to be rolled out in future.

Gk Current Affairs April 2017

28 APRIL
NEWS
27 APRIL
NEWS
26 APRIL
NEWS
25 APRIL
NEWS

Gk Current Affairs March 2017

31 MARCH
NEWS
30 MARCH
NEWS
29 MARCH
NEWS
28 MARCH
NEWS

Gk Current Affairs February 2017

28 FEBRUARY
NEWS
27 FEBRUARY
NEWS
25 FEBRUARY
NEWS
24 FEBRUARY
NEWS




Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.

Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.